Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Grants & Contracts
Research output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
13-THY-03-AZ (D4203C00011) [VERIFY]Phase III Study of Vandetanib in Advanced Radioiodine Refractory Thyroid Cancers
Ain, Kenneth
(PI)
Markey Cancer Center / Cancer Research Priority Initiative
Overview
Grants and Contracts Details
Status
Finished
Effective start/end date
1/8/14
→
6/30/17
Funding
AstraZeneca Pharmaceuticals AB:
$399,586.00
View all
View less